No hidden fees – just official clinic prices. Pay at the clinic for Hepatitis С treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hepatitis С treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hepatitis С treatment journey.
Dr. Yogesh Batra heads the Gastroenterology and Hepatology Department at BLK Super Speciality Hospital. He is a recognized expert in treating viral hepatitis and complex liver conditions. Dr. Batra trained at AIIMS New Delhi, India’s top-ranked medical institute. He received the Young Investigator Award from the Indian Society of Gastroenterology.
Generic Hep C medications in India show success rates between 91% and 98%. These direct-acting antivirals (DAAs) achieve a complete cure. Specialists measure this by a sustained virological response 12 weeks after treatment. This effectiveness matches expensive brand-name versions exactly.
Bookimed Expert Insight: India is Bookimed's second-ranked global destination. Clinics like Apollo Hospital Indraprastha and Medanta serve over 1,000,000 patients annually. Specialised hepatologists like Dr Yogesh Batra at BLK Super Speciality Hospital bring over 20 years of experience. This high patient volume and expertise helps even complex genotype variations receive precise dosing protocols.
Patient Consensus: Patients note that India's generic regimens produce a complete cure. This happens when the medicine matches their specific genotype. They emphasise finishing the full course and verifying medication authenticity through hospitals like Medanta.
Generic Hepatitis C medications in India generally do not cause severe side effects. Clinical studies show these generics have a safety profile identical to brand-name drugs. Modern direct-acting antivirals (DAAs) like Sofosbuvir and Daclatasvir are well tolerated by most patients. These medications are usually taken over 8–24 week courses.
Bookimed Expert Insight: India is a hub for Hepatitis C care, with 92 clinics serving over 5,880 international patients. Top hepatologists like Dr Yogesh Batra at BLK Super Speciality Hospital have over 20 years of experience. While patients often worry about generic quality, leading facilities like Artemis or Manipal hold JCI and NABH accreditations. These credentials show that medication sources meet strict international safety standards.
Patient Consensus: Patients in India feel supported when clinics provide interpreters and airport transfers. Most describe symptoms like insomnia or gastrointestinal upset as annoying rather than dangerous. They note that confirming the drug manufacturer beforehand provides peace of mind.
Hepatitis C treatment in India typically lasts 12 weeks. Patients use oral Direct-Acting Antiviral (DAA) medications. Effective pangenotypic drugs like Sofosbuvir with Velpatasvir or Daclatasvir are the standard. Treatment may extend to 24 weeks for complex cases involving cirrhosis.
Bookimed Expert Insight: India is a global hub for DAA production. Major centres like Artemis Hospitals and Apollo Hospital Indraprastha provide immediate access to medication. Specialists like Dr Yogesh Batra provide these once they confirm the liver status. Our data shows patients often complete diagnostics and obtain medication within 10 days of arrival.
Patient Consensus: Patients in India find the all-oral tablet daily routine very manageable. They note it is essential to confirm genotype and liver status before starting the course.
Patients do not need to stay in India for the full 8–12 week Hepatitis C treatment. Most specialists prescribe Direct-Acting Antiviral tablets. These allow patients to return home after initial testing and medication collection. JCI-accredited hospitals in Delhi and Bengaluru frequently support this. Follow-up occurs remotely or with a local GP.
Bookimed Expert Insight: India remains the top choice for Hepatitis C due to high patient volumes at major centres. For example, the Manipal Hospitals network serves 2,000,000 patients annually. Because of this massive scale, hepatologists like Dr Yogesh Batra at BLK Super Speciality Hospital are experienced in coordinating full medication supplies. This makes the transition back to Australia seamless.
Patient Consensus: Patients find the process efficient, often coordinating treatment prices and airport transfers within 10 days. They highlight that having a translator and hospital-provided transport makes navigating a foreign country much easier while starting medication.
International patients may legally travel to India for Hepatitis C treatment using a dedicated medical visa. Indian hospitals provide access to licensed Direct-Acting Antiviral medications. Access requires an official hospital invitation and a medical referral from a local GP or specialist.
Bookimed Expert Insight: India is the second most requested destination globally for specialised care. Major network hospitals like Manipal or Apollo serve over 1,000,000 patients annually. High patient volumes allow these centres to maintain large stocks of generic antivirals. Specialists like Dr Yogesh Batra at BLK Super Speciality Hospital have over 20 years of experience managing complex liver cases. This expertise helps treatment plans meet international standards while navigating local pharmacy regulations.
Patient Consensus: Patients note that hospitals like Medanta often coordinate airport transfers. They also provide interpreters to assist during doctor visits. Many find the quick organisation and constant contact with coordinators helps them feel comfortable in an unfamiliar country.